Automated deep-learning system for Gleason grading of prostate cancer using biopsies: a diagnostic study
- PMID: 31926805
- DOI: 10.1016/S1470-2045(19)30739-9
Automated deep-learning system for Gleason grading of prostate cancer using biopsies: a diagnostic study
Abstract
Background: The Gleason score is the strongest correlating predictor of recurrence for prostate cancer, but has substantial inter-observer variability, limiting its usefulness for individual patients. Specialised urological pathologists have greater concordance; however, such expertise is not widely available. Prostate cancer diagnostics could thus benefit from robust, reproducible Gleason grading. We aimed to investigate the potential of deep learning to perform automated Gleason grading of prostate biopsies.
Methods: In this retrospective study, we developed a deep-learning system to grade prostate biopsies following the Gleason grading standard. The system was developed using randomly selected biopsies, sampled by the biopsy Gleason score, from patients at the Radboud University Medical Center (pathology report dated between Jan 1, 2012, and Dec 31, 2017). A semi-automatic labelling technique was used to circumvent the need for manual annotations by pathologists, using pathologists' reports as the reference standard during training. The system was developed to delineate individual glands, assign Gleason growth patterns, and determine the biopsy-level grade. For validation of the method, a consensus reference standard was set by three expert urological pathologists on an independent test set of 550 biopsies. Of these 550, 100 were used in an observer experiment, in which the system, 13 pathologists, and two pathologists in training were compared with respect to the reference standard. The system was also compared to an external test dataset of 886 cores, which contained 245 cores from a different centre that were independently graded by two pathologists.
Findings: We collected 5759 biopsies from 1243 patients. The developed system achieved a high agreement with the reference standard (quadratic Cohen's kappa 0·918, 95% CI 0·891-0·941) and scored highly at clinical decision thresholds: benign versus malignant (area under the curve 0·990, 95% CI 0·982-0·996), grade group of 2 or more (0·978, 0·966-0·988), and grade group of 3 or more (0·974, 0·962-0·984). In an observer experiment, the deep-learning system scored higher (kappa 0·854) than the panel (median kappa 0·819), outperforming 10 of 15 pathologist observers. On the external test dataset, the system obtained a high agreement with the reference standard set independently by two pathologists (quadratic Cohen's kappa 0·723 and 0·707) and within inter-observer variability (kappa 0·71).
Interpretation: Our automated deep-learning system achieved a performance similar to pathologists for Gleason grading and could potentially contribute to prostate cancer diagnosis. The system could potentially assist pathologists by screening biopsies, providing second opinions on grade group, and presenting quantitative measurements of volume percentages.
Funding: Dutch Cancer Society.
Copyright © 2020 Elsevier Ltd. All rights reserved.
Comment in
-
Deep-learning approaches for Gleason grading of prostate biopsies.Lancet Oncol. 2020 Feb;21(2):187-189. doi: 10.1016/S1470-2045(19)30793-4. Epub 2020 Jan 8. Lancet Oncol. 2020. PMID: 31926804 No abstract available.
-
Algorithms May Assist Expert Pathologists in Prostate Cancer Diagnosis.Cancer Discov. 2020 Mar;10(3):OF1. doi: 10.1158/2159-8290.CD-RW2020-012. Epub 2020 Jan 17. Cancer Discov. 2020. PMID: 31953243
Similar articles
-
Artificial intelligence assistance significantly improves Gleason grading of prostate biopsies by pathologists.Mod Pathol. 2021 Mar;34(3):660-671. doi: 10.1038/s41379-020-0640-y. Epub 2020 Aug 5. Mod Pathol. 2021. PMID: 32759979 Free PMC article.
-
Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study.Lancet Oncol. 2020 Feb;21(2):222-232. doi: 10.1016/S1470-2045(19)30738-7. Epub 2020 Jan 8. Lancet Oncol. 2020. PMID: 31926806
-
Deep learning for automatic Gleason pattern classification for grade group determination of prostate biopsies.Virchows Arch. 2019 Jul;475(1):77-83. doi: 10.1007/s00428-019-02577-x. Epub 2019 May 16. Virchows Arch. 2019. PMID: 31098801 Free PMC article.
-
Contemporary Gleason Grading of Prostatic Carcinoma: An Update With Discussion on Practical Issues to Implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.Am J Surg Pathol. 2017 Apr;41(4):e1-e7. doi: 10.1097/PAS.0000000000000820. Am J Surg Pathol. 2017. PMID: 28177964
-
The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.Am J Surg Pathol. 2016 Feb;40(2):244-52. doi: 10.1097/PAS.0000000000000530. Am J Surg Pathol. 2016. PMID: 26492179 Review.
Cited by
-
Detection of Muscularis propria Invasion in Urothelial Carcinoma Using Artificial Intelligence.Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241257479. doi: 10.1177/15330338241257479. Technol Cancer Res Treat. 2024. PMID: 38803309 Free PMC article.
-
Artificial intelligence enables precision diagnosis of cervical cytology grades and cervical cancer.Nat Commun. 2024 May 22;15(1):4369. doi: 10.1038/s41467-024-48705-3. Nat Commun. 2024. PMID: 38778014 Free PMC article.
-
A comprehensive AI model development framework for consistent Gleason grading.Commun Med (Lond). 2024 May 9;4(1):84. doi: 10.1038/s43856-024-00502-1. Commun Med (Lond). 2024. PMID: 38724730 Free PMC article.
-
Applications of artificial intelligence in urologic oncology.Investig Clin Urol. 2024 May;65(3):202-216. doi: 10.4111/icu.20230435. Investig Clin Urol. 2024. PMID: 38714511 Free PMC article. Review.
-
Advances in the study of tertiary lymphoid structures in the immunotherapy of breast cancer.Front Oncol. 2024 Apr 2;14:1382701. doi: 10.3389/fonc.2024.1382701. eCollection 2024. Front Oncol. 2024. PMID: 38628669 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials